Pharma Pulse 2/24/25: Enhancing Pharma Supply Chain Transparency and Trust, Growing Obesity Crisis is Driving Up Healthcare Costs & more

Enhancing Pharma Supply Chain Transparency and Trust

In the third part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Laura Johnson, senior director of sales, life sciences, Loftware, discusses why the demand for supply chain transparency is continuing to gain momentum, while also explaining the role that track-and-trace initiatives are playing in that effort.

How the Growing Obesity Crisis is Driving Up Healthcare Costs

Obesity rates have spiked over the past few decades, displaying itself a significant crisis.

Why AI Spending Isn’t Slowing Down

Soaring demand for reasoning models will consume electricity, microchips and data-center real estate for the foreseeable future.

Nuclera Appoints Seth Benson as Chief Financial Officer

Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced that it has appointed Seth Benson as Chief Financial Officer. Seth joins CEO, Dr Michael Chen, on the executive team to advance commercial and strategic initiatives, drive revenue and support expansion of the business following the close of the Company’s USD $75 million financing round.¹

Noah Fishbein on LinkedIn

Data—often referred to as digital gold—has become one of the most pressing topics for pharma commercial teams today.

In a recent Pharmaceutical Executive article, Kunal Girotra breaks down the traditional segmentation approach, which primarily focuses on historical prescribing behavior. He highlights how this strategy can now be significantly enhanced through Guided Flexibility—leveraging descriptive and predictive analytics to identify broad engagement patterns while empowering field teams with the autonomy to adjust their approach based on real-time HCP interactions.

This concept of flexibility isn’t limited to field teams. I’ve seen it play a key role in peer-to-peer and non-personal marketing strategies, where the most effective teams prioritize value-driven engagement over sheer volume.

Enabling HCPs to share authentic stories and patient experiences creates a deeper level of advocacy—something a banner impression simply can’t replicate. The real opportunity lies in how we capture and apply the value within our data-driven narratives. Done right, this could be a game-changer in building truly impactful engagement strategies.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs